Fredolini, Claudia http://orcid.org/0000-0002-7674-2014
Dodig-Crnković, Tea
Bendes, Annika http://orcid.org/0000-0001-9329-2353
Dahl, Leo http://orcid.org/0000-0003-1492-3052
Dale, Matilda http://orcid.org/0000-0002-5788-7744
Albrecht, Vincent http://orcid.org/0009-0003-1985-7733
Mattsson, Cecilia
Thomas, Cecilia E. http://orcid.org/0000-0001-6201-6380
Torinsson Naluai, Åsa http://orcid.org/0000-0002-0504-6492
Gisslen, Magnus
Beck, Olof
Roxhed, Niclas http://orcid.org/0000-0002-7147-6730
Schwenk, Jochen M. http://orcid.org/0000-0001-8141-8449
Funding for this research was provided by:
VINNOVA (2020-04451)
Familjen Erling-Perssons Stiftelse (Future-proofing against COVID-19)
Knut och Alice Wallenbergs Stiftelse (Human Protein Atlas, WASP)
Science for Life Laboratory (2020.0182, 2020.0241, VC-2022-04451)
Article History
Received: 12 October 2022
Accepted: 7 March 2024
First Online: 2 April 2024
Competing interests
: O.B. and N.R. are co-founders of Capitainer AB, a company that commercialized the blood collection device for microsampling. J.M.S. has, unrelated to the presented work, received speaker fees from Roche Diagnostics, travel support from Luminex Corp. and Olink AB, and conducted contract research for Luminex Corp. and Capitainer AB. All other authors declare no competing interests.